- Report
- March 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- March 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- March 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- March 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- February 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- February 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- February 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- February 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- February 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- February 2025
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- November 2024
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- November 2024
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- November 2024
- 150 Pages
Global
From €4326EUR$4,850USD£3,719GBP
- Report
- August 2024
- 224 Pages
Global
From €4456EUR$4,995USD£3,831GBP
- Report
- February 2024
- 177 Pages
Global
€4456EUR$4,995USD£3,831GBP
- Report
- January 2024
- 106 Pages
Global
€4456EUR$4,995USD£3,831GBP
- Report
- June 2025
- 265 Pages
Global
From €4456EUR$4,995USD£3,831GBP
- Report
- August 2026
- 160 Pages
From €2962EUR$3,320USD£2,546GBP
€3702EUR$4,150USD£3,183GBP
- Report
- August 2026
- 160 Pages
From €2962EUR$3,320USD£2,546GBP
€3702EUR$4,150USD£3,183GBP
- Report
- August 2026
- 160 Pages
From €2962EUR$3,320USD£2,546GBP
€3702EUR$4,150USD£3,183GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more